Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Autoimmune Disorders

  Free Subscription


1 Am J Kidney Dis
1 Ann Neurol
2 BMC Neurol
4 Diabet Med
1 Diabetes
1 J Autoimmun
1 J Immunol
8 J Neuroimmunol
2 J Neurol
1 J Pediatr
1 Kidney Int
2 Lancet Neurol
4 Mult Scler
1 Nat Rev Neurol
3 Neurology
9 PLoS One
3 Proc Natl Acad Sci U S A
1 Thyroid

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Kidney Dis

  1. YU GZ, Guo L, Dong JF, Shi SF, et al
    Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
    Am J Kidney Dis. 2020 Mar 18. pii: S0272-6386(19)31166.
    PubMed         Abstract available

    Ann Neurol

  2. PITSCH J, Kamalizade D, Braun A, Kuehn JC, et al
    Drebrin autoantibodies in patients with seizures and suspected encephalitis.
    Ann Neurol. 2020 Mar 20. doi: 10.1002/ana.25720.
    PubMed         Abstract available

    BMC Neurol

  3. YPERMAN J, Becker T, Valkenborg D, Popescu V, et al
    Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis.
    BMC Neurol. 2020;20:105.
    PubMed         Abstract available

  4. ZHANG X, Lang Y, Sun L, Zhang W, et al
    Clinical characteristics and prognostic analysis of anti-gamma-aminobutyric acid-B (GABA-B) receptor encephalitis in Northeast China.
    BMC Neurol. 2020;20:1.
    PubMed         Abstract available

    Diabet Med

  5. DUE-CHRISTENSEN M, Willaing I, Ismail K, Forbes A, et al
    Learning about Type 1 diabetes and learning to live with it when diagnosed in adulthood: two distinct but inter-related psychological processes of adaptation evaluated in a qualitative longitudinal study.
    Diabet Med. 2018 Oct 17. doi: 10.1111/dme.13838.
    PubMed         Abstract available

  6. LAWTON J, Blackburn M, Rankin D, Allen J, et al
    The impact of using a closed-loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents.
    Diabet Med. 2018 Dec 21. doi: 10.1111/dme.13887.
    PubMed         Abstract available

  7. WRIGHT LA, Hirsch IB
    Non-insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions.
    Diabet Med. 2019 Feb 22. doi: 10.1111/dme.13941.
    PubMed         Abstract available

  8. BROWN SA, Basu A, Kovatchev BP
    Beyond HbA1c : using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision-making.
    Diabet Med. 2019;36:679-687.
    PubMed         Abstract available


  9. LOPES-VIRELLA MF, Bebu I, Hunt KJ, Virella G, et al
    Immune Complexes and the Risk of CVD in Type 1 Diabetes.
    Diabetes. 2019 Jun 19. pii: db19-0358. doi: 10.2337/db19-0358.
    PubMed         Abstract available

    J Autoimmun

  10. MUHAMMAD F, Wang D, McDonald T, Walsh M, et al
    TIGIT(+) A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis.
    J Autoimmun. 2020 Mar 20:102441. doi: 10.1016/j.jaut.2020.102441.
    PubMed         Abstract available

    J Immunol

  11. DENG Z, Law CS, Ho FO, Wang KM, et al
    A Defect in Thymic Tolerance Causes T Cell-Mediated Autoimmunity in a Murine Model of COPA Syndrome.
    J Immunol. 2020 Mar 20. pii: jimmunol.2000028. doi: 10.4049/jimmunol.2000028.
    PubMed         Abstract available

    J Neuroimmunol

  12. TAHMASEBIVAND M, Mousavi SR, Khorrami M, Ayromlou H, et al
    miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta.
    J Neuroimmunol. 2020;342:577212.
    PubMed         Abstract available

  13. COVACU R, Brundin L
    Endogenous spinal cord stem cells in multiple sclerosis and its animal model.
    J Neuroimmunol. 2016 Nov 15. pii: S0165-5728(16)30403.
    PubMed         Abstract available

  14. VOLPE G, Bernstock JD, Peruzzotti-Jametti L, Pluchino S, et al
    Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.
    J Neuroimmunol. 2016 Dec 15. pii: S0165-5728(16)30312.
    PubMed         Abstract available

  15. ANTEL JP, Lin YH, Cui QL, Pernin F, et al
    Immunology of oligodendrocyte precursor cells in vivo and in vitro.
    J Neuroimmunol. 2019;331:28-35.
    PubMed         Abstract available

    Regenerative neuroimmunology: The impact of immune and neural stem cell interactions for translation in neurodegeneration and repair.
    J Neuroimmunol. 2019;331:1-3.

  17. KAUSHANSKY N, Kaminitz A, Allouche-Arnon H, Ben-Nun A, et al
    Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c(+)CD11b(+)Gr1(+) myeloid-derived dendritic cells.
    J Neuroimmunol. 2019;333:476953.
    PubMed         Abstract available

  18. DURCAN R, Heffron C, Sweeney B
    Natalizumab induced cutaneous sarcoidosis-like reaction.
    J Neuroimmunol. 2019;333:476955.
    PubMed         Abstract available

  19. MCGILL MM, Sabikunnahar B, Fang Q, Teuscher C, et al
    The sex-specific role of p38 MAP kinase in CNS autoimmunity is regulated by estrogen receptor alpha.
    J Neuroimmunol. 2020;342:577209.

    J Neurol

  20. HERRAETS IJT, Bakers JNE, van Eijk RPA, Goedee HS, et al
    Human immune globulin 10% with recombinant human hyaluronidase in multifocal motor neuropathy.
    J Neurol. 2019;266:2734-2742.
    PubMed         Abstract available

  21. LECLER A, Bouzad C, Deschamps R, Maizeroi F, et al
    Optimizing 3D FLAIR to detect MS lesions: pushing past factory settings for precise results.
    J Neurol. 2019;266:2786-2795.
    PubMed         Abstract available

    J Pediatr

    50 Years Ago in TheJournal ofPediatrics: Occurrence of Systemic Lupus Erythematosus in Association with Ethosuccimide Therapy.
    J Pediatr. 2020;219:53.

    Kidney Int

  23. PONTICELLI C, Moroni G
    Discontinuation of therapy in lupus nephritis.
    Kidney Int. 2020;97:806-807.

    Lancet Neurol

  24. FILIPPI M, Rocca MA
    Rethinking multiple sclerosis treatment strategies.
    Lancet Neurol. 2020;19:281-282.

  25. HE A, Merkel B, Brown JWL, Zhovits Ryerson L, et al
    Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
    Lancet Neurol. 2020;19:307-316.
    PubMed         Abstract available

    Mult Scler

  26. OTURAI DB, Bach Sondergaard H, Koch-Henriksen N, Andersen C, et al
    Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis.
    Mult Scler. 2020 Mar 23:1352458520912500. doi: 10.1177/1352458520912500.
    PubMed         Abstract available

  27. DADAR M, Narayanan S, Arnold DL, Collins DL, et al
    Conversion of diffusely abnormal white matter to focal lesions is linked to progression in secondary progressive multiple sclerosis.
    Mult Scler. 2020 Mar 23:1352458520912172. doi: 10.1177/1352458520912172.
    PubMed         Abstract available

  28. JACOBS BM, Giovannoni G, Cuzick J, Dobson R, et al
    Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.
    Mult Scler. 2020 Mar 23:1352458520907901. doi: 10.1177/1352458520907901.
    PubMed         Abstract available

  29. DEMORTIERE S, Rico A, Maarouf A, Boutiere C, et al
    Maintenance of natalizumab during the first trimester of pregnancy in active multiple sclerosis.
    Mult Scler. 2020 Mar 23:1352458520912637. doi: 10.1177/1352458520912637.
    PubMed         Abstract available

    Nat Rev Neurol

  30. BARNETT C, Bril V
    New insights into very-late-onset myasthenia gravis.
    Nat Rev Neurol. 2020 Mar 17. pii: 10.1038/s41582-020-0345.


  31. RINGELSTEIN M, Harmel J, Zimmermann H, Brandt AU, et al
    Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
    Neurology. 2020;94:e407-e418.
    PubMed         Abstract available

  32. NEUMANN B, Angstwurm K, Mergenthaler P, Kohler S, et al
    Myasthenic crisis demanding mechanical ventilation: A multicenter analysis of 250 cases.
    Neurology. 2020;94:e299-e313.
    PubMed         Abstract available

  33. OUDEMAN J, Eftimov F, Strijkers GJ, Schneiders JJ, et al
    Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies.
    Neurology. 2019 Dec 11. pii: WNL.0000000000008697.
    PubMed         Abstract available

    PLoS One

  34. MAYO M, Chepulis L, Paul RG
    Glycemic-aware metrics and oversampling techniques for predicting blood glucose levels using machine learning.
    PLoS One. 2019;14:e0225613.
    PubMed         Abstract available

  35. LI Y, Higgs RE, Hoffman RW, Dow ER, et al
    A Bayesian gene network reveals insight into the JAK-STAT pathway in systemic lupus erythematosus.
    PLoS One. 2019;14:e0225651.
    PubMed         Abstract available

  36. ELSO CM, Scott NA, Mariana L, Masterman EI, et al
    Replacing murine insulin 1 with human insulin protects NOD mice from diabetes.
    PLoS One. 2019;14:e0225021.
    PubMed         Abstract available

  37. ONDREJKOVA M, Jackuliak P, Martinka E, Mokan M, et al
    Prevalence and epidemiological characteristics of patients with diabetic retinopathy in Slovakia: 12-month results from the DIARET SK study.
    PLoS One. 2019;14:e0223788.
    PubMed         Abstract available

  38. CHEN HH, Lin CH, Chen DY, Chao WC, et al
    Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study.
    PLoS One. 2019;14:e0222860.
    PubMed         Abstract available

  39. LIN SD, Butler JE, Boswell-Ruys CL, Hoang P, et al
    The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience.
    PLoS One. 2019;14:e0222731.
    PubMed         Abstract available

  40. GROENER JB, Valkanou A, Kender Z, Pfeiffenberger J, et al
    Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes.
    PLoS One. 2019;14:e0222771.
    PubMed         Abstract available

  41. HAMMOND CL, Roztocil E, Phipps RP, Feldon SE, et al
    Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor.
    PLoS One. 2019;14:e0222779.
    PubMed         Abstract available

  42. JIANG N, Li M, Zhang M, Xu J, et al
    Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus.
    PLoS One. 2019;14:e0225516.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  43. COSTANZA M, Poliani PL, Portararo P, Cappetti B, et al
    DNA threads released by activated CD4(+) T lymphocytes provide autocrine costimulation.
    Proc Natl Acad Sci U S A. 2019;116:8985-8994.
    PubMed         Abstract available

  44. LI Y, James SJ, Wyllie DH, Wynne C, et al
    TMEM203 is a binding partner and regulator of STING-mediated inflammatory signaling in macrophages.
    Proc Natl Acad Sci U S A. 2019;116:16479-16488.
    PubMed         Abstract available

  45. SCHUBART A, Anderson K, Mainolfi N, Sellner H, et al
    Small-molecule factor B inhibitor for the treatment of complement-mediated diseases.
    Proc Natl Acad Sci U S A. 2019;116:7926-7931.
    PubMed         Abstract available


  46. LIU Y, Cui X, Wang S, Liu J, et al
    Elevated microRNA-326 levels regulate the IL-23/IL-23R/Th17 cell axis in Hashimoto's thyroiditis by targeting a disintegrin and metalloprotease 17.
    Thyroid. 2020 Mar 24. doi: 10.1089/thy.2019.0552.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.